Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy
Clinical trial NCT01299545 · TERMINATED
Trial details
- NCT number
- NCT01299545
- Sponsor
- TcLand Expression S.A.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-10-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.